Clinical trials
Observational Muscular Atrophy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
72 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 8 |
| 2022 | 2 |
| 2023 | 8 |
| 2024 | 6 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Unknown status | 8 |
| Recruiting | 7 |
| Not yet recruiting | 6 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amsterdam UMC, location VUmc | 3 |
| University Hospital, Basel, Switzerland | 3 |
| University of Nottingham | 3 |
| Guy's and St Thomas' NHS Foundation Trust | 2 |
| Jinling Hospital, China | 2 |
| University of Exeter | 2 |
| University of Malaya | 2 |
| Ain Shams University | 1 |
| Asian Institute of Gastroenterology, India | 1 |
| Assiut University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Atrophy | 72 |
| Critical Illness | 18 |
| Sarcopenia | 14 |
| Muscle Weakness | 7 |
| Asthenia | 3 |
| Bone Diseases, Metabolic | 3 |
| COVID-19 | 3 |
| Malnutrition | 3 |
| Muscular Diseases | 3 |
| Atrophy | 2 |
Trials
Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.